Overview
Houcai Wang practices practicing medicine in Shanghai, China.
Their clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Multiple Myeloma, Leukemia, and Adult T-Cell Leukemia.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Houcai Wang
Is Houcai Wang a top-rated expert for Chronic Myelogenous Leukemia (CML)?
MediFind is an objective health platform that identifies experts based on real-world data. Houcai Wang is classified as an Experienced expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Houcai Wang participate in research or clinical trials?
Yes. Houcai Wang has published 15 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Houcai Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult T-Cell LeukemiaWang isExperienced. Learn about Adult T-Cell Leukemia.
- Chronic Myelogenous Leukemia (CML)
- LeukemiaWang isExperienced. Learn about Leukemia.
- Multiple MyelomaWang isExperienced. Learn about Multiple Myeloma.